Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
30.10
-2.61 (-7.98%)
At close: Nov 21, 2024, 4:00 PM
31.00
+0.90 (2.99%)
After-hours: Nov 21, 2024, 4:31 PM EST
Structure Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for GPCR stock have an average target of 86.8, with a low estimate of 65 and a high estimate of 118. The average target predicts an increase of 188.37% from the current stock price of 30.10.
Analyst Consensus: Buy
* Price targets were last updated on Sep 23, 2024.
Analyst Ratings
The average analyst rating for GPCR stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 5 | 5 | 5 | 6 | 6 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +115.95% | Sep 23, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $118 | Buy | Initiates | $118 | +292.03% | Sep 23, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +115.95% | Sep 16, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +115.95% | Sep 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +115.95% | Aug 19, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
56.67M
EPS This Year
-0.79
from -2.44
EPS Next Year
-0.79
from -0.79
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 525.0M | n/a | ||
| Avg | n/a | 56.7M | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.62 | 2.15 | -1.46 | ||
| Avg | -0.79 | -0.79 | -1.53 | ||
| Low | -0.87 | -1.41 | -1.61 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.